(ORMP) Oramed Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Oramed Pharmaceuticals | (ORMP) share price targets
Complete technical analysis of Oramed Pharmaceuticals (ORMP) by charts plus indicators, forecast predictions and share price targets for Oramed Pharmaceuticals (ORMP)
Oramed Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-08-14 View latest technical analysis
10 day averaged volume of Oramed Pharmaceuticals is 108337
Date | Daily Closing Price | Open | High | Low | Volume |
14 Wed Aug 2024 | 2.24 | 2.34 | 2.43 | 2.23 | 1.408 times |
13 Tue Aug 2024 | 2.36 | 2.35 | 2.43 | 2.30 | 0.574 times |
12 Mon Aug 2024 | 2.32 | 2.26 | 2.43 | 2.26 | 0.808 times |
09 Fri Aug 2024 | 2.34 | 2.34 | 2.38 | 2.31 | 0.557 times |
08 Thu Aug 2024 | 2.37 | 2.27 | 2.40 | 2.22 | 1.102 times |
07 Wed Aug 2024 | 2.21 | 2.35 | 2.35 | 2.21 | 0.792 times |
06 Tue Aug 2024 | 2.35 | 2.22 | 2.35 | 2.21 | 0.624 times |
05 Mon Aug 2024 | 2.21 | 2.13 | 2.33 | 2.10 | 1.883 times |
02 Fri Aug 2024 | 2.34 | 2.35 | 2.39 | 2.28 | 1.375 times |
01 Thu Aug 2024 | 2.37 | 2.46 | 2.52 | 2.37 | 1.316 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 2.3, but if it comes above 2.3, then a intra day buy could be more profitable.
If you take a sell trade below 2.3, then use 2.3 as stoploss and 2.1 as target. However if you take a buy trade in stock , then use 2.3 as stoploss and 2.43 as target.
Share price targets for Oramed Pharmaceuticals (ORMP)
Target Type | Value |
Downside Target | 2.00 |
Downside Target | 2.10 |
Downside Target | 2.23 |
Upside Target | 2.28 |
Upside Target | 2.35 |
Upside Target | 2.40 |
Upside Target | 2.50 |
Upside Target | 2.60 |
Upside Target | 2.67 |
Upside Target | 2.78 |
Upside Target | 2.95 |
Intraday share price targets for Oramed Pharmaceuticals (ORMP)
Target Type | Value |
Downside Intraday Target | 2.17 |
Downside Intraday Target | 2.1 |
Upside Intraday Target | 2.37 |
Upside Intraday Target | 2.5 |
Upside Intraday Target | 2.3 |
Weekly technical analysis of Oramed Pharmaceuticals (ORMP)
Date | Weekly Closing Price | Open | High | Low | Volume |
14 Wed Aug 2024 | 2.24 | 2.26 | 2.43 | 2.23 | 0.563 times |
09 Fri Aug 2024 | 2.34 | 2.13 | 2.40 | 2.10 | 0.874 times |
02 Fri Aug 2024 | 2.34 | 2.55 | 2.60 | 2.28 | 1.596 times |
26 Fri Jul 2024 | 2.60 | 2.55 | 2.67 | 2.52 | 1.022 times |
19 Fri Jul 2024 | 2.55 | 2.51 | 2.60 | 2.50 | 0.809 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Oramed Pharmaceuticals (ORMP)
Date | Monthly Closing Price | Open | High | Low | Volume |
14 Wed Aug 2024 | 2.24 | 2.46 | 2.52 | 2.10 | 0.583 times |
31 Wed Jul 2024 | 2.55 | 2.56 | 2.67 | 2.35 | 0.455 times |
28 Fri Jun 2024 | 2.57 | 2.17 | 2.78 | 2.00 | 2.118 times |
31 Fri May 2024 | 2.18 | 2.29 | 2.55 | 2.15 | 0.864 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Oramed Pharmaceuticals (ORMP)
Price action analysis of Oramed Pharmaceuticals ( (ORMP) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Oramed Pharmaceuticals ( (ORMP) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Oramed Pharmaceuticals ( (ORMP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Oramed Pharmaceuticals ( (ORMP) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Oramed Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Oramed Pharmaceuticals in short term and the sell signal is strong.
Oramed Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Oramed Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Oramed Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.3 and Oramed Pharmaceuticals (ORMP) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Oramed Pharmaceuticals (ORMP) stock. Volume based technical analysis of Oramed Pharmaceuticals (ORMP) stock is negative.
Oramed Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Oramed Pharmaceuticals ( (ORMP) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Oramed Pharmaceuticals ( (ORMP) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Oramed Pharmaceuticals ( (ORMP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Oramed Pharmaceuticals ( (ORMP) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Oramed Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Oramed Pharmaceuticals in short term and the sell signal is strong.
Oramed Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Oramed Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Oramed Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.3 and Oramed Pharmaceuticals (ORMP) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Oramed Pharmaceuticals (ORMP) stock. Volume based technical analysis of Oramed Pharmaceuticals (ORMP) stock is negative.
Oramed Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.